1. (a) A pharmacist who tests for conditions under Arkansas Code § 17-92-101(18)(A)(x) shall:

   1. (1) Hold a license to practice pharmacy in this state;
   2. (2) Report a diagnosis or suspected existence of reportable diseases as required by the Department of Health;
   3. (3) Furnish patient records to a healthcare practitioner designated by the patient upon the request of the patient; and
   4. (4) Maintain records of all patients receiving services under this section for two (2) years.

2. (b) A pharmacist may treat the following conditions within the framework of a statewide written protocol:

   1. (1) Influenza;
   2. (2) Pharyngitis caused by Streptococcus A;
   3. (3) SARS coronavirus; or
   4. (4) Other health conditions adopted by rule according to the Pharmacy Practice Act.

3. (c)

   1. (1) The Arkansas State Board of Pharmacy shall publish the statewide written protocol as developed and adopted with consultation and approval of the Arkansas State Medical Board.

   2. (2) The statewide written protocol:

      1. (A) Shall include the age of people that can be treated under the protocol;
      2. (B) Shall include medicinal drugs approved by the Food and Drug Administration that are indicated for treatment of these conditions, including without limitation any over-the-counter medication; and
      3. (C) Shall not include any controlled substances in Schedules I – IV.

4. (d) A pharmacist shall only treat conditions:

   1. (1) For which the pharmacist has tested; and
   2. (2) That are approved under Arkansas Code § 17-92-101(18)(A)(x)(c) or Arkansas State Board of Pharmacy rules as described in statute.
5. (e) This section does not apply to specific acts of drug therapy management or disease state management delegated to a pharmacist based upon a written protocol or patient care plan approved by a physician, Arkansas Code § 17-92-101.

Codification Notes: This section as promulgated prior to codification into the Code of Arkansas Rules provided as follows: “(Adopted 5/10/2022)"